Acute myelopathy following chimeric antigen receptor (CAR) T cell therapy: an unusual diagnostic challenge

• by Antoine Bois, Corentin Provost, Justine Decroocq, Sarah Benghanem

• October 8, 2026

Late enhancement and washout maps for distinguishing tumor progression from radiation necrosis in malignant brain tumors: an exploratory study

• by Eya Khadhraoui, Leon Schmidt, Stefan Klebingat, I Erol Sandalcioglu, Roland Schwab, Philipp Arndt, Daniel Behme, Klaus-Peter Stein, Sebastian Johannes Müller

• October 15, 2026

2026 ASCO Breast Cancer Highlights: PANKU-Breast02

Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD discuss new results from the PANKU-Breast02 Study on a new dual-antibody drug conjugate, called izalontamab brengitecan (iza-bren), for metastatic triple-negative breast cancer.

• October 15, 2026

• 1 min

Error in Supplement 2

• October 19, 2026